Basal Ganglia Pathophysiology
1 – 10 of 192
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Structural-functional properties of direct-pathway striatal neurons at early and chronic stages of dopamine denervation
(
- Contribution to journal › Article
-
Mark
Cells, pathways, and models in dyskinesia research
(
- Contribution to journal › Scientific review
-
Mark
Pericyte Microvesicles as Plasma Biomarkers Reflecting Brain Microvascular Signaling in Patients with Acute Ischemic Stroke
(
- Contribution to journal › Article
- 2023
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Models and biomarkers of motor and neuropsychiatric complications in Parkinson’s disease
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Distinctive Effects of D1 and D2 Receptor Agonists on Cortico-Basal Ganglia Oscillations in a Rodent Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Article
- 2022
-
Mark
Non‐Apoptotic Caspase‐3 Activation Mediates Early Synaptic Dysfunction of Indirect Pathway Neurons in the Parkinsonian Striatum
(
- Contribution to journal › Article